Asia Pacific Cellular Health Screening Market Size & Outlook
Asia Pacific cellular health screening market, 2018-2030 (US$M)
Related Markets
Asia Pacific cellular health screening market highlights
- The Asia Pacific cellular health screening market generated a revenue of USD 471.8 million in 2023.
- The market is expected to grow at a CAGR of 10.7% from 2024 to 2030.
- In terms of segment, single test panels was the largest revenue generating test type in 2023.
- Multi-test Panels is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 471.8 million |
| Market revenue in 2030 | USD 959.9 million |
| Growth rate | 10.7% (CAGR from 2023 to 2030) |
| Largest segment | Single test panels |
| Fastest growing segment | Multi-test Panels |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Single Test Panels, Multi-test Panels |
| Key market players worldwide | Cytek Biosciences Inc, Quest Diagnostics Inc, Labcorp Holdings Inc, OPKO Health Inc, Applied DNA Sciences Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 15.6% of the global cellular health screening market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 959.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cellular Health Screening Market Scope
Cellular Health Screening Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific cellular health screening market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cellular health screening market will help companies and investors design strategic landscapes.
Single test panels was the largest segment with a revenue share of 77.83% in 2023. Horizon Databook has segmented the Asia Pacific cellular health screening market based on single test panels, multi-test panels covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is the fastest-growing region globally owing to presence of a large patient population and growing economies. The driving factors of Asia Pacific cellular health screening market include improving adoption and awareness of telomere performance programs by countries, growing awareness of healthy life expectancy, increasing government attention on preventive healthcare, growing geriatric population, and rising burden of chronic disorders.
However, the market is restrained by factors such as obstacles linked with transporting samples and price differences in test kits offered by different manufacturers.
Reasons to subscribe to Asia Pacific cellular health screening market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific cellular health screening market databook
-
Our clientele includes a mix of cellular health screening market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cellular health screening market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cellular health screening market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific cellular health screening market size, by country, 2018-2030 (US$M)
Asia Pacific Cellular Health Screening Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
